Orji Ogbonnaya, Dlamini Zandile, Wise Amy J
Department of Obstetrics and Gynaecology, Faculty of Health Sciences, University of the Witwatersrand, Johannesburg, South Africa.
S Afr J Infect Dis. 2022 Jan 28;37(1):343. doi: 10.4102/sajid.v37i1.343. eCollection 2022.
Urinary tract infection (UTI) in pregnancy is associated with significant morbidity for both the mother and the foetus. The aim of this study was to determine the prevalence of UTI, urinary bacterial susceptibility, and resistance patterns among pregnant women with a possible UTI at Rahima Moosa Mother and Child Hospital (RMMCH) in Johannesburg.
In this retrospective study, we analysed mid-stream urine culture and antibiotic susceptibility data from both inpatients and outpatients of pregnant women who attended RMMCH from January 2017 to December 2017. Data were collected from patients' files and then matched with urine microscopy, sensitivity and culture (MC&S) results from the National Health Laboratory Services (NHLS) data.
Urine microscopy, cultures and sensitivities were performed on 1984 specimens belonging to pregnant women who presented with symptoms and/or signs of a UTI. A total of 333 patients (16.8%) had positive bacterial cultures. (E. coli) was the commonest bacterial isolate (49.9%). Other microorganisms isolated included Klebsiella species (14.4%), Enterococcus faecalis (12.9%) and coagulase-negative staphylococci (CoNS); (8.9%). Approximately 98% of organisms were sensitive to cephalexin. Cefuroxime (95.2%), ceftriaxone/cefotaxime (94.4%) and nitrofurantoin (81.9%) demonstrated antimicrobial effectiveness as indicated. Most isolates were resistant to ampicillin/amoxicillin (84.4%), Trimethoprim/Sulfamethoxazole (55.6%) and amoxicillin-clavulanic acid (50.2%).
was the commonest pathogen causing UTIs in pregnancy with Enterococcus faecalis increasing in prevalence. The choice of antimicrobial therapy in pregnancy should be determined according to sensitivity and resistance and foeto-maternal safety.
妊娠期尿路感染(UTI)对母亲和胎儿均有显著的发病率影响。本研究的目的是确定约翰内斯堡拉希玛·穆萨母婴医院(RMMCH)中可能患有UTI的孕妇中UTI的患病率、尿液细菌敏感性和耐药模式。
在这项回顾性研究中,我们分析了2017年1月至2017年12月在RMMCH就诊的孕妇住院患者和门诊患者的中段尿培养及抗生素敏感性数据。数据从患者病历中收集,然后与国家卫生实验室服务(NHLS)数据中的尿显微镜检查、敏感性和培养(MC&S)结果进行匹配。
对1984份属于有UTI症状和/或体征的孕妇的标本进行了尿显微镜检查、培养和敏感性检测。共有333例患者(16.8%)细菌培养呈阳性。大肠埃希菌是最常见的分离细菌(49.9%)。分离出的其他微生物包括克雷伯菌属(14.4%)、粪肠球菌(12.9%)和凝固酶阴性葡萄球菌(CoNS);(8.9%)。约98%的微生物对头孢氨苄敏感。头孢呋辛(95.2%)、头孢曲松/头孢噻肟(94.4%)和呋喃妥因(81.9%)显示出抗菌效果。大多数分离株对氨苄西林/阿莫西林(84.4%)、甲氧苄啶/磺胺甲恶唑(55.6%)和阿莫西林-克拉维酸(50.2%)耐药。
大肠埃希菌是妊娠期引起UTI的最常见病原体,粪肠球菌的患病率在增加。妊娠期抗菌治疗的选择应根据敏感性和耐药性以及母婴安全性来确定。